vOPG147-deficiency promotes innate immune response to VACV. by Xue-Mei Yi (18851202)

OPG147 is associated with MITA. by Xue-Mei Yi (18851202)

OPG147-deficiency promotes innate immune response to MPXV. by Xue-Mei Yi (18851202)

Changes associated with kidney fibrosis and effects of MN705 treatment on TGF- by Wencheng Jin (13136262)

Example of a participant using the elevated surface (20 cm) during the intermittent footrest use (A) and the intermittent footrest use with arm flexion, hands crossed on the clavic... by Saeedeh Abbasi (9423189)

Number of habituation sessions (mean ± standard deviation) of weaned piglets and gilts per batch (1, 2), habituation stage (different group sizes, individual), duration per habitua... by Sara Hintze (3216885)

Differences among the classes of CAMs. by Daniel P. Bradley (10306893)

“…A representative HPD <b>1466</b>, with a 50% effective concentration against HBV replication of 0.25 µM, decreased capsid and core protein accumulation by 50–90% in HepDES19 and HepG2.2.15 cells. …”

OPG147 contributes to VACV evasion of host defense and is a virulence factor <i>in vivo.</i> by Xue-Mei Yi (18851202)

Changes related to kidney staining in UUO mouse model. by Wencheng Jin (13136262)

Changes associated with kidney fibrosis in TGF- by Wencheng Jin (13136262)

The screening process of MN705. by Wencheng Jin (13136262)

Validation of MN705 treatment effects in human proximal tubular epithelial cells during TGF- by Wencheng Jin (13136262)

Effect of MN705 treatment on TGF- by Wencheng Jin (13136262)

Dynamics of EGFP and mRFP fluorescence in infected cells under different heat shock conditions. by Enrique Paz-Cortés (20988196)

Subjects:

Length distribution and condition factors <i>K</i> of <i>E. erythropterus</i> (A) before and (B) after the NRE opening. by Jeong-Soo Gim (18058588)

Baseline characteristics of the study population. by Hanbin Wu (14016246)

“…In addition to paying attention to women with preconception hyperglycemia, our findings call for increased concern for women with hypoglycemia in preconception glycemic screening, with consideration of modified effects by preconception BMI, which might be worth exploring as a means to reduce adverse pregnancy outcomes.</p></div>…”

Line graph illustrating mean random blood glucose (mmol/L) at weekly intervals during the induction phase. by Elsie D. Oduor (22521785)

Mean lesion depth of the SDF test groups and the SDF-free group at baseline and post-cycling time points. by Suphanida Kaewkamchai (19762172)

Line graph illustrating mean random blood glucose (mmol/L) at weekly intervals during the treatment phase. by Elsie D. Oduor (22521785)

Mean mineral density of the SDF test groups and the SDF-free group at baseline and post-cycling time points. by Suphanida Kaewkamchai (19762172)